← Leaderboards
Peter Q Eichacker
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Top investigators on “Bacterial Disease”
- Myron Max Levine · University Of Maryland Baltimore$116,795,600
- Barbara Driver · Westat, Inc.$95,592,456
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Donald Ym Leung · University Of Colorado Denver$38,763,371
Research focus
Bacterial DiseaseLaboratory RatDisease /Disorder ModelBlood ToxicologyInflammationDrug Screening /EvaluationNonhuman Therapy EvaluationLipopolysaccharidesNitric OxideSepticemiaCytokineBioterrorism /Chemical WarfareBacterial Cytopathogenic EffectBacillus AnthracisAnimalsAntiinflammatory AgentsHemodynamicsAnimal ModelLungEscherichia ColiAnthrax Lethal FactorLaboratory MouseDoseCardiopulmonary
Grant awards (57)
The Effects of B. anthracis Cell Wall in a Small Animal Model$54,000
Z01 · FY2008 · CL · contact PI
Canine Model Investigating Cardiopulmonary Effects B. anthracis Edema and Lethal$53,962
Z01 · FY2008 · CL · contact PI
Prognostic Value of High-resolution Computed Tomography Scan in Murine Pneumonia$53,962
Z01 · FY2008 · CL · contact PI
Selective inhibition of p38 mitogen activated protein kinase with the pyridinyl$53,962
Z01 · FY2008 · CL · contact PI
Canine Model Investigating Cardiopulmonary Effects B. anthracis Edema and Lethal$44,443
Z01 · FY2007 · CL · contact PI
The Effects of B. anthracis Cell Wall in a Small Animal Model$44,403
Z01 · FY2007 · CL · contact PI
Comparison of Anthrax Edema and Lethal Toxins in a Rat Model$44,403
Z01 · FY2007 · CL · contact PI
Effects of Fluid Treatment in a B. Anthracis Lethal Toxin Challenged Rat Model$44,403
Z01 · FY2007 · CL · contact PI
NF-kappa B in Murine Sepsis$44,403
Z01 · FY2007 · CL · contact PI
Prognostic Value of High-resolution Computed Tomography Scan in Murine Pneumonia$44,403
Z01 · FY2007 · CL · contact PI
Selective inhibition of p38 mitogen activated protein kinase with the pyridinyl$44,403
Z01 · FY2007 · CL · contact PI
Prognostic Value of High-resolution Computed Tomography$0
Z01 · FY2006 · CL · contact PI
Selective inhibition of p38 mitogen activated protein ki$0
Z01 · FY2006 · CL · contact PI
The Effects of B. anthracis Cell Wall in a Small Animal$0
Z01 · FY2006 · CL · contact PI
Canine Model Investigating Cardiopulmonary Effects B. an$0
Z01 · FY2006 · CL · contact PI
Comparison of Anthrax Edema and Lethal Toxins in a Rat M$0
Z01 · FY2006 · CL · contact PI
Effects of Fluid Treatment in a B. Anthracis Lethal Toxi$0
Z01 · FY2006 · CL · contact PI
NF-kappa B in Murine Sepsis$0
Z01 · FY2006 · CL · contact PI
Steroid and Heparin Treatment in a Murine Sepsis Model$0
Z01 · FY2005 · CL
Effects of Fluid Treatment in a B. Anthracis Lethal Toxi$0
Z01 · FY2005 · CL
Comparison of Anthrax Edema and Lethal Toxins in a Rat$0
Z01 · FY2005 · CL
Pretreatment with Sublethal B. Anthracis Lethal Toxin$0
Z01 · FY2005 · CL
Nitric Oxide Inhibition With DTPA/Fe3--Rat Model Sepsis$0
Z01 · FY2005 · CL
NF-kappa B in Murine Sepsis$0
Z01 · FY2005 · CL
An Anthrax Lethal Toxin Model Of Sepsis$0
Z01 · FY2005 · CL
PA-mAb in a Rat Model of Anthrax Sepsis$0
Z01 · FY2005 · CL
Fluid Treatment in B. Anthracis Lethal Toxin Rat Model$0
Z01 · FY2004 · CL
Influence Of Site, Severity, And Type Of Infection On Ef$0
Z01 · FY2004 · CL
Anthrax Lethal Toxin Model Of Sepsis$0
Z01 · FY2004 · CL
Nitric Oxide Inhibition With DTPA/Fe3 In Rat Sepsis Mode$0
Z01 · FY2004 · CL
NF-kappa B in Murine Sepsis$0
Z01 · FY2004 · CL
Steroid and Heparin Treatment in a Murine Sepsis Model$0
Z01 · FY2004 · CL
PA-mAb in a Rat Model of Anthrax Sepsis$0
Z01 · FY2004 · CL
Pretreatment Sublethal B. Anthracis Lethal Toxin in Rats$0
Z01 · FY2004 · CL
Influence Of Site, Severity, And Type Of Infection On Ef$0
Z01 · FY2003 · CL
NF-kappa B in Murine Sepsis$0
Z01 · FY2003 · CL
The Influence Of Infection Duration On TNFMAb In Sepsis$0
Z01 · FY2003 · CL
Nitric Oxide Inhibition With Dtpa/fe3 In A Rat Model Of$0
Z01 · FY2003 · CL
Effect Of Graded Levels Of Infection On Gene Expression$0
Z01 · FY2003 · CL
An Anthrax Lethal Toxin Model Of Sepsis$0
Z01 · FY2003 · CL
Site,severity&Infection Type Influence On Superoxide Di$0
Z01 · FY2003 · CL
Site,severity&Infection Type Influence On Superoxide Di$0
Z01 · FY2002 · CL
The Influence Of Infection Duration On Tnf ab In Sepsis$0
Z01 · FY2002 · CL
Nitric Oxide Inhibition With Dtpa/fe3 In Model of Sepsis$0
Z01 · FY2002 · CL
Effect Of Graded Levels Of Infection On Gene Expression$0
Z01 · FY2002 · CL
An Anthrax Lethal Toxin Model Of Sepsis$0
Z01 · FY2002 · CL
Influence Of Site, Severity, And Type Of Infection On Ef$0
Z01 · FY2002 · CL
Factors Influencing Effects of Endotoxin Analogs$0
Z01 · FY2001 · CL
Site,severity&Infection Type Influence On Superoxide Di$0
Z01 · FY2001 · CL
Influence Of Systemic Inflammation On The Effects Of Rec$0
Z01 · FY2001 · CL
Factors Influencing Antiinflammatory Effects$0
Z01 · FY2001 · CL
Previous Infection And Host Defense Effects of GCSF$0
Z01 · FY2001 · CL
The Influence of Fluid Administration on the Effects of Tumor Necrosis Factor So$0
Z01 · FY2000 · CL
TYPE OF INFECTION ON TYROSINE KINASE INHIBITOR$0
Z01 · FY2000 · CL
EFFECTS OF TUMOR NECROSIS FACTOR MONOCLONAL ANTIBODIES$0
Z01 · FY2000 · CL
TYPE OF INFECTION ON EFFECTS OF ENDOTOXIN ANALOG$0
Z01 · FY2000 · CL
Influence of Previous Infection on the Host Defense Effects of Granulocyte Colon$0
Z01 · FY2000 · CL